Corrigendum to “Rowe P et al. safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A” [Contraception 2016;93:498–506]

Detalles Bibliográficos
Autores principales: Rowe, Patrick, Farley, Tim, Peregoudov, Alexandre, Piaggio, Gilda, Boccard, Simone, Landoulsi, Sihem, Meirik, Olav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357721/
https://www.ncbi.nlm.nih.gov/pubmed/27312266
http://dx.doi.org/10.1016/j.contraception.2016.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357721/
https://www.ncbi.nlm.nih.gov/pubmed/27312266
http://dx.doi.org/10.1016/j.contraception.2016.06.001

Ejemplares similares